Functionalized mesoporous silica nanoparticles for innovative boron-neutron capture therapy of resistant cancers
G. Vares, V. Jallet, Y. Matsumoto, C. Rentier, K. Takayama, T. Sasaki, Y. Hayashi, H. Kumada, H. Sugawara
This study develops B-MSNs for BNCT to treat chondrosarcomas, showing DNA damage and cell death in radio-resistant CSCs.
bioRxiv · Nov 18, 2019Cancer Biology